Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Penson

Showing results (261-270 of 570) with videos related to

Pageof 57
Sort By:
The Journal of Urology|April 8, 2006
Prostate cancer on the Internet--information or misinformation?Peter C Black, David F Penson
The New England Journal of Medicine|April 26, 2013
Functional outcomes after treatment for prostate cancerMatthew J Resnick, David F Penson
BJU International|November 22, 2016
'Killing two birds with one stone': patient-reported quality-of-life outcomes from the Prostate Testing for Cancer and Treatment (ProtecT) trialMark D Tyson, David F Penson
The Journal of Urology|April 22, 2014
Re: use of statins and the risk of death in patients with prostate cancerSamir S Taneja, David F Penson
Surgical Oncology|May 29, 2002
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdomDavid F Penson, Peter C Albertsen
Urologic Oncology|May 24, 2005
Quality of life in patients with localized prostate cancerMarcus L Quek, David F Penson
BJU International|June 13, 2018
Multiparametric magnetic resonance imaging (MRI) with targeted fusion biopsy: is the time now?Aaron A Laviana, David F Penson
The Journal of Urology|January 24, 2012
Re: What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trialAlan J Wein, David F Penson
Reviews in Urology|September 30, 2017
A discussion on the AUA castrateresistant prostate cancer guidelinesDavid M Albala, David F Penson
BJU International|June 18, 2010
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapDaniel A Barocas, David F Penson
Pageof 57

Showing results (261-270 of 570) with videos related to

Sort By:
Pageof 57
The Journal of Urology|April 8, 2006
Prostate cancer on the Internet--information or misinformation?Peter C Black, David F Penson
The New England Journal of Medicine|April 26, 2013
Functional outcomes after treatment for prostate cancerMatthew J Resnick, David F Penson
BJU International|November 22, 2016
'Killing two birds with one stone': patient-reported quality-of-life outcomes from the Prostate Testing for Cancer and Treatment (ProtecT) trialMark D Tyson, David F Penson
The Journal of Urology|April 22, 2014
Re: use of statins and the risk of death in patients with prostate cancerSamir S Taneja, David F Penson
Surgical Oncology|May 29, 2002
Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdomDavid F Penson, Peter C Albertsen
Urologic Oncology|May 24, 2005
Quality of life in patients with localized prostate cancerMarcus L Quek, David F Penson
BJU International|June 13, 2018
Multiparametric magnetic resonance imaging (MRI) with targeted fusion biopsy: is the time now?Aaron A Laviana, David F Penson
The Journal of Urology|January 24, 2012
Re: What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trialAlan J Wein, David F Penson
Reviews in Urology|September 30, 2017
A discussion on the AUA castrateresistant prostate cancer guidelinesDavid M Albala, David F Penson
BJU International|June 18, 2010
Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gapDaniel A Barocas, David F Penson
Pageof 57